KOSDAQ · Healthcare · ₩1T
₩34,900-1.55%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 15.7% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“신약 개발 기반이 넓어져 다음 성장 기회를 키우고 있어요.”
In the company's words · 2026 2분기 filing